Variation in price of cardiovascular and diabetes medicine in Indonesia, and relationship with quality: a mixed methods study in East Java

Abstract excerpt

Lower-middle income Indonesia, the world’s fourth most populous country, has struggled to contain costs in its mandatory, single-payer public health insurance system since the system’s inception in 2014. Public procurement policies radically reduced prices of most medicines in public facilities and the wider market. However, professional associations and the press have questioned the quality of these low-cost, unb...

Topics

Open a Topic to create a Post that cites this publication.

• Cost-Benefit Analysis
• Drug Discovery
• Interferons
• Oligopeptides
• Ribavirin
• Ritonavir
• Sofosbuvir
• Switzerland

Identifiers and source

Literature Corpus work

83ddf6fe-e4a8-5b1f-b1f8-22141a36846b

DOI

10.1101/2022.11.24.22282722